New maintenance drug shows promise for lymphoma patients with hepatitis b
Disease control
Completed
This study tested the drug chidamide as a maintenance treatment for 30 people with a type of lymphoma (DLBCL) who also have hepatitis B. All participants had finished chemotherapy and their cancer was in complete remission. The goal was to see if chidamide could help keep the can…
Phase: PHASE2 • Sponsor: Ou Bai, MD/PHD • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC